KANBAK, G. Et Al. 2011. Cardiovascular risk assessment in patients with type 2 diabetes mellitus and metabolic syndrome: Role of biomarkers. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS , vol.5, no.1 , 7-11.

KANBAK, G., AKALIN, A., Dokumacioglu, A., Ozcelik, E., & BAL, C., (2011). Cardiovascular risk assessment in patients with type 2 diabetes mellitus and metabolic syndrome: Role of biomarkers. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS , vol.5, no.1, 7-11.

KANBAK, GÜNGÖR Et Al. "Cardiovascular risk assessment in patients with type 2 diabetes mellitus and metabolic syndrome: Role of biomarkers," DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS , vol.5, no.1, 7-11, 2011

KANBAK, GÜNGÖR Et Al. "Cardiovascular risk assessment in patients with type 2 diabetes mellitus and metabolic syndrome: Role of biomarkers." DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS , vol.5, no.1, pp.7-11, 2011

KANBAK, G. Et Al. (2011) . "Cardiovascular risk assessment in patients with type 2 diabetes mellitus and metabolic syndrome: Role of biomarkers." DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS , vol.5, no.1, pp.7-11.

@article{article, author={GÜNGÖR KANBAK Et Al. }, title={Cardiovascular risk assessment in patients with type 2 diabetes mellitus and metabolic syndrome: Role of biomarkers}, journal={DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS}, year=2011, pages={7-11} }